An announcement from BioSig Technologies Inc (BSGM) is now available.
BioSig Technologies, Inc. has strengthened its board with the appointment of three new independent directors: Steven E. Abelman, a seasoned commercial litigator with expertise in bankruptcy and transactional law; Donald F. Browne, a CPA with a strong background in business accounting and tax reporting; and Chris Baer, whose previous announcement adds depth to the board. These strategic appointments, set to serve until the next annual stockholders’ meeting, signal BioSig’s commitment to robust governance and financial oversight, aligning with NASDAQ’s listing requirements and SEC regulations.
Learn more about BSGM stock on TipRanks’ Stock Analysis page.
